The Discounted Cash Flow (DCF) valuation of Dermapharm Holding SE (DMP.DE) is 44.54 EUR. With the latest stock price at 35.20 EUR, the upside of Dermapharm Holding SE based on DCF is 26.5%.
Based on the latest price of 35.20 EUR and our DCF valuation, Dermapharm Holding SE (DMP.DE) is a buy. buying DMP.DE stocks now will result in a potential gain of 26.5%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.1% | 6.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 27.09 - 91.55 | 44.54 |
| Upside | -23.0% - 160.1% | 26.5% |